• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXHL2100071 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXHL2100072 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXHL2100073 IBI362注射液 mazdutide Injection Chemical Drugs(1) New Drug Application 2021-01-29 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd In Review 2021-01-28 view
CXSB1700005 重组人抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products Supplementary Application 2017-08-18 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-01-17 view
CXSB1900010 信迪利单抗注射液 sintilimab Injection Biological Products Supplementary Application 2019-05-16 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2019-06-05 view
CXSB2000004 信迪利单抗注射液 sintilimab Injection Biological Products Supplementary Application 2020-02-14 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2020-09-29 view
CXSB2100002 信迪利单抗注射液 sintilimab Injection Biological Products(原1) Supplementary Application 2021-01-06 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2021-09-02 view
CXSL1200088 重组人-鼠嵌合抗CD20单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2013-02-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2014-09-24 view
CXSL1400002 重组人抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2014-02-17 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-01-13 view
CXSL1400005 重组人抗肿瘤坏死因子-α单克隆抗体注射液 adalimumab Injection Biological Products(2) New Drug Application 2014-02-19 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-01-13 view
CXSL1500008 重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液 Injection Biological Products(1) New Drug Application 2015-04-21 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-12-22 view
CXSL1500009 重组人血管内皮生长因子受体-抗体-人补体受体1融合蛋白注射液 Injection Biological Products(1) New Drug Application 2015-04-21 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-12-22 view
CXSL1500010 重组抗VEGF人源化单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2015-04-21 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-05-19 view
CXSL1500044 重组抗VEGF人源化单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2015-05-25 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-05-19 view
CXSL1500136 IBI308 sintilimab Injection Biological Products(1) New Drug Application 2016-01-25 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2016-09-04 view
CXSL1600128 重组全人源抗前蛋白转化酶枯草溶菌素9(PCSK-9)单克隆抗体注射液 Injection Biological Products(1) New Drug Application 2017-02-13 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2017-09-27 view
CXSL1800012 注射用重组全人源抗肿瘤坏死因子受体超家族成员4(OX40)单克隆抗体 Lyophilized Biological Products(1) New Drug Application 2018-02-09 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-07-06 view
CXSL1800074 IBI188 letaplimab Injection Biological Products(1) New Drug Application 2018-07-04 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-09-03 view
CXSL1800081 重组抗VEGF人源化单克隆抗体注射液 Injection Biological Products(2) New Drug Application 2018-07-30 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-10-08 view
CXSL1800082 信迪利单抗注射液 sintilimab Injection Biological Products(1) New Drug Application 2018-07-30 信达生物制药(苏州)有限公司 Innovent Biologics (Suzhou) Co Ltd Certificate Issued 2018-10-08 view